MD Atlas update: Jun 6, 2026

S.A.L.F. S.p.A. Laboratorio Farmacologico

IT-PR-000026314

System / procedure pack producerActive

Address: Via G. Marconi, 2 24069 Cenate Sotto
Role: System / procedure pack producer
Date of registration: Jul 21, 2022
Country: Italy

Is this your company? Claim it to add your logo, story and links — free.Claim this page

S.A.L.F. S.p.A. Laboratorio Farmacologico is a system and procedure pack producer registered in EUDAMED. Headquartered in Cenate Sotto, Italy. Explore the regulatory profile, devices and certificates on MD Atlas.

Role
Country
Date of registration
Address

MD Atlas update: Jun 6, 2026

S.A.L.F. S.p.A. Laboratorio Farmacologico

IT-PR-000026314

System / procedure pack producerActive

Address: Via G. Marconi, 2 24069 Cenate Sotto
Role: System / procedure pack producer
Date of registration: Jul 21, 2022
Country: Italy

Is this your company? Claim it to add your logo, story and links — free.Claim this page

About S.A.L.F.

SRN An SRN is the unique EUDAMED identifier assigned to a manufacturer, authorised representative or importer when it registers as an actor. View in glossary →: IT-PR-000026314
Role: System / procedure pack producer
Country: Italy
Organization name: S.A.L.F. S.p.A. Laboratorio Farmacologico
EU VAT number: 00226250165
Trade register: BG-124751
Date of registration: Jul 21, 2022

Contact details for S.A.L.F.

Phone: +39 035940097
Email: regulatory@salfspa.it
Website: https://www.salfspa.it/
Address: 2, VIA G. MARCONI 24069 CENATE SOTTO ITALY

Competent authority

Name: Ministero della salute - Direzione generale dei dispositivi medici e del servizio farmaceutico
SRN An SRN is the unique EUDAMED identifier assigned to a manufacturer, authorised representative or importer when it registers as an actor. View in glossary →: IT-CA-070
Phone: +39 06 5994 3199/ +39 06 5994 3207
Email: segr.dgfdm@sanita.it

Role and obligations in EUDAMED

A producer of systems or procedure packs combines CE-marked devices to place a system or procedure pack on the market under the conditions of Article 22 of the MDR (2017/745).